Prospective cohort study to investigate the clinical factors associated with the prognosis of newly diagnosed multiple myeloma in National Hospital Organization

Prospective cohort study to investigate the clinical factors associated with the prognosis of newly diagnosed multiple myeloma in National Hospital Organization - NHO MM Cohort Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014270

Enrollment

400

Registered

2014-08-01

Start date

2014-10-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MGUS, plasmacytoma and multiple myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MUGUS, plasmacytoma and multiple myeloma.

Exclusion criteria

Exclusion criteria: A history of the chemotherapy for multiple myeloma.

Design outcomes

Primary

Measure	Time frame
Progression free survival (PFS) according to the initial chemotherapy of patients with symptomatic multiple myeloma.	—

Secondary

Measure	Time frame
Overall survival (OS)and treatment toxicity of patients with symptomatic multiple myeloma. Extension rate from MGUS or SMM to symptomatic myeloma. The process evaluation of the diagnosis and treatment of multiple myeloma.	—

Countries

Japan

Contacts

Public ContactTakuya Komeno

National Hospital Organization Mito Medical Center Department of Hematology

komeno.takuya.ze@mail.hosp.go.jp029-240-7711

Outcome results